In a public alert, the FDA reported at least 12 cases of serious eye infection in Florida patients treated with Genentech's injectable drug Avastin that was repackaged at a pharmacy. Meanwhile, a Tennessee newspaper reported that four patients were given shots with bacterial contamination. Avastin is approved to treat cancer but is used off-label to treat wet age-related macular degeneration.

Related Summaries